Routine versus clinically indicated replacement of peripheral intravenous catheters: A randomised controlled equivalence trial

The Lancet

Volumn 380, Issue 9847, 2012, Pages 1066-1074

  Rickard, Claire M ^a,b,e   Webster, Joan ^a,b   Wallis, Marianne C ^a,f   Marsh, Nicole ^a   McGrail, Matthew R ^d   French, Venessa ^e   Foster, Lynelle ^f   Gallagher, Peter ^e   Gowardman, John R ^a,c   Zhang, Li ^a   McClymont, Alice ^b   Whitby, Michael ^a,e  

^a GRIFFITH UNIVERSITY   (Australia)

^b Centre for Clinical Nursing   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d UNIVERSITY OF BALLARAT   (Australia)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

^f GOLD COAST UNIVERSITY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTRIBUTABLE RISK; AUSTRALIA; CATHETER INFECTION; CATHETER REMOVAL; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHLEBITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VEIN CATHETERIZATION;

EID: 84866491780     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61082-4     Document Type: Article

References (35)

1. Maki DG. Improving the safety of peripheral intravenous catheters. BMJ 2008; 337: 122-23.
2. Zingg W, Pittet D. Peripheral venous catheters: an under-evaluated problem. Int J Antimicrob Agents 2009; 34: S38-42.
3. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006; 81: 1159-71.
4. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011; 52: e162-93.
5. Cook D, Randolph AG, Kernerman P, et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 1997; 25: 1417-24.
6. Bregenzer T, Conen D, Sakmann P, Widmer AF. Is routine replacement of peripheral intravenous catheters necessary? Arch Intern Med 1998; 158: 151-56.
7. Cornely OA, Bethe U, Pauls R, Waldschmidt D. Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation. Infect Control Hosp Epidemiol 2002; 23: 249-53.
8. Grune F, Schrappe M, Basten J, Wenchel H, Tual E, Stutzer H. Phlebitis rate and time kinetics of short peripheral IV catheters. Infection 2004; 32: 30-32.
9. Rickard CM, McCann D, Munnings J, McGrail MR. Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial. BMC Med 2010; 8: 53.
10. Van Donk P, Rickard CM, McGrail MR, Doolan G. Routine replacement versus clinical monitoring of peripheral intravenous catheters in a regional hospital in the home program: a randomized controlled trial. Infect Control Hosp Epidemiol 2009; 30: 915-17.
11. Webster J, Clarke S, Paterson D, et al. Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial. BMJ 2008; 337: a339.
12. Webster J, Lloyd S, Hopkins T, Osborne S, Yaxley M. Developing a Research base for Intravenous Peripheral cannula re-sites (DRIP trial). A randomised controlled trial of hospital in-patients. Int J Nurs Stud 2007; 44: 664-71.
13. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. Ann Intern Med 1991; 114: 845-54.
14. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002; 23: 759-69.
15. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977; 296: 1305-09.
16. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ 2000; 320: 1197-200.
17. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters: gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA 1987; 258: 2396-403.
18. Lee WL, Chen HL, Tsai TY, et al. Risk factors for peripheral intravenous catheter infection in hospitalized patients: a prospective study of 3165 patients. Am J Infect Control 2009; 37: 683-86.
19. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45.
20. Elliott TSJ, Moss HA, Tebbs SE, et al. Novel approach to investigate a source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis 1997; 16: 210-13.
21. Zhang L, Gowardman J, Rickard C. Impact of microbial attachment on intravascular catheter-related infections. Int J Antimicrob Agents 2011; 38: 9-15.
22. Schultz AA, Gallant P. Evidence-based quality improvement project for determining appropriate discontinuation of peripheral IV cannulas. Evid Based Nurs 2005; 8: 8.
23. Palese A, Cassone A, Kulla A, et al. Factors influencing nurses' decision-making process on leaving in the peripheral intravascular catheter after 96 hours: a longitudinal study. J Infus Nurs 2011; 34: 319-26.
24. Bravery K, Dougherty L, Gabriel J, Kayley J, Malster M, Scales K. Audit of peripheral venous cannulae by members of an IV therapy forum. Br J Nurs 2006; 15: 1244-49.
25. Johansson M, Pilhammar E, Willman A. Nurses' clinical reasoning concerning management of peripheral venous cannulae. J Clin Nurs 2009; 18: 366-75.
26. Gaukroger PB, Roberts JG, Manners TA. Infusion thrombophlebitis: a prospective comparison of 645 Vialon and Teflon cannulae in anaesthetic and postoperative use. Anaesth Intensive Care 1988; 16: 265-71.
27. Bausone-Gazda D, Lefaiver CA, Walters C-A. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter-stabilization systems. J Infus Nurs 2010; 33: 371-84.
28. Schears GJ. Summary of product trials for 10,164 patients: comparing an intravenous stabilizing device to tape. J Infus Nurs 2006; 29: 225-31.
29. Gallant P, Schultz AA. Evaluation of a visual infusion phlebitis scale for determining appropriate discontinuation of peripheral intravenous catheters. J Infus Nurs 2006; 29: 338-45.
30. Malach T, Jerassy Z, Rudensky B, et al. Prospective surveillance of phlebitis associated with peripheral intravenous catheters. Am J Infect Control 2006; 34: 308-12.
31. Powell J, Tarnow KG, Perucca R. The relationship between peripheral intravenous catheter indwell time and the incidence of phlebitis. J Infus Nurs 2008; 31: 39-45.
32. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998; 158: 473-77.
33. Chico-Padron RM, Carrion-Garcia L, Delle-Vedove-Rosales L, et al. Comparative safety and costs of transparent versus gauze wound dressings in intravenous catheterization. J Nurs Care Qual 2011; 26: 371-76.
34. Smith B. Peripheral intravenous catheter dwell times. A comparison of 3 securement methods for implementation of a 96-hour scheduled change protocol. J Infus Nurs 2006; 29: 14-17.
35. Webster J, Osborne S, Rickard C, Hall J. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev 2010; 17: CD007798.